Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00898404 · ClinicalTrials.gov registry record
Response or Resistance to Chemotherapy in Young Patients With Acute Lymphoblastic Leukemia Treated With Methotrexate
A clinical trial, sponsored by Children's Oncology Group.
- Completed
- Registry status
- 150
- Enrollment target
NCT00898404 is a clinical trial that has completed, run by Children's Oncology Group. The registered enrollment target is 150 participants.
The verdict
NCT00898404 has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
Study Summary
This laboratory study is looking at response or resistance to chemotherapy in young patients with acute lymphoblastic leukemia treated with methotrexate. Studying samples of tumor tissue in the laboratory from patients with cancer may help doctors learn more about changes that occur in DNA and drug resistance in patients.
Interventions
- OTHER laboratory biomarker analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2003-11 |
| Est. Completion | 2016-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00898404
The ClinicalTrials.gov registry entry for NCT00898404 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Oncology Group, which has 342 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which laboratory biomarker analysis is the first listed.
NCT00898404 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00898404 about?
NCT00898404 is a clinical study titled "Response or Resistance to Chemotherapy in Young Patients With Acute Lymphoblastic Leukemia Treated With Methotrexate". This laboratory study is looking at response or resistance to chemotherapy in young patients with acute lymphoblastic leukemia treated with methotrexate. Studying samples of tumor tissue in the laboratory from patients with cancer may help doctors learn more about changes that occur in DNA and drug ...
What is the current status of trial NCT00898404?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2003-11. Estimated completion is 2016-05.
What interventions are being tested in trial NCT00898404?
The interventions under investigation include: laboratory biomarker analysis (OTHER).
Who is sponsoring clinical trial NCT00898404?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.